Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.
This report aims to provide a comprehensive presentation of the global market for Large Molecule Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Molecule Injectable Drugs. This report contains market size and forecasts of Large Molecule Injectable Drugs in global, including the following market information:
Global Large Molecule Injectable Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Large Molecule Injectable Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Intravenous Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Large Molecule Injectable Drugs include Biogen, AstraZeneca, Roche, Sun Pharmaceutical, Medtronic, Novartis, ??Baxter, Amgen and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Large Molecule Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Large Molecule Injectable Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, by Type, 2022 (%)
Intravenous Injection
Muscle Injection
Subcutaneous Injection
Global Large Molecule Injectable Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Large Molecule Injectable Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Large Molecule Injectable Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Large Molecule Injectable Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
??Baxter
Amgen
Pfizer
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Large Molecule Injectable Drugs, market overview.
Chapter 2: Global Large Molecule Injectable Drugs market size in revenue.
Chapter 3: Detailed analysis of Large Molecule Injectable Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Large Molecule Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Large Molecule Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Large Molecule Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Large Molecule Injectable Drugs Overall Market Size
2.1 Global Large Molecule Injectable Drugs Market Size: 2022 VS 2030
2.2 Global Large Molecule Injectable Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Large Molecule Injectable Drugs Players in Global Market
3.2 Top Global Large Molecule Injectable Drugs Companies Ranked by Revenue
3.3 Global Large Molecule Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Large Molecule Injectable Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Large Molecule Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Large Molecule Injectable Drugs Players in Global Market
3.6.1 List of Global Tier 1 Large Molecule Injectable Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Large Molecule Injectable Drugs Market Size Markets, 2022 & 2030
4.1.2 Intravenous Injection
4.1.3 Muscle Injection
4.1.4 Subcutaneous Injection
4.2 By Type - Global Large Molecule Injectable Drugs Revenue & Forecasts
4.2.1 By Type - Global Large Molecule Injectable Drugs Revenue, 2018-2023
4.2.2 By Type - Global Large Molecule Injectable Drugs Revenue, 2024-2030
4.2.3 By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Large Molecule Injectable Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Large Molecule Injectable Drugs Revenue & Forecasts
5.2.1 By Application - Global Large Molecule Injectable Drugs Revenue, 2018-2023
5.2.2 By Application - Global Large Molecule Injectable Drugs Revenue, 2024-2030
5.2.3 By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Large Molecule Injectable Drugs Market Size, 2022 & 2030
6.2 By Region - Global Large Molecule Injectable Drugs Revenue & Forecasts
6.2.1 By Region - Global Large Molecule Injectable Drugs Revenue, 2018-2023
6.2.2 By Region - Global Large Molecule Injectable Drugs Revenue, 2024-2030
6.2.3 By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Large Molecule Injectable Drugs Revenue, 2018-2030
6.3.2 US Large Molecule Injectable Drugs Market Size, 2018-2030
6.3.3 Canada Large Molecule Injectable Drugs Market Size, 2018-2030
6.3.4 Mexico Large Molecule Injectable Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Large Molecule Injectable Drugs Revenue, 2018-2030
6.4.2 Germany Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.3 France Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.4 U.K. Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.5 Italy Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.6 Russia Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Large Molecule Injectable Drugs Market Size, 2018-2030
6.4.8 Benelux Large Molecule Injectable Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Large Molecule Injectable Drugs Revenue, 2018-2030
6.5.2 China Large Molecule Injectable Drugs Market Size, 2018-2030
6.5.3 Japan Large Molecule Injectable Drugs Market Size, 2018-2030
6.5.4 South Korea Large Molecule Injectable Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Large Molecule Injectable Drugs Market Size, 2018-2030
6.5.6 India Large Molecule Injectable Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Large Molecule Injectable Drugs Revenue, 2018-2030
6.6.2 Brazil Large Molecule Injectable Drugs Market Size, 2018-2030
6.6.3 Argentina Large Molecule Injectable Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, 2018-2030
6.7.2 Turkey Large Molecule Injectable Drugs Market Size, 2018-2030
6.7.3 Israel Large Molecule Injectable Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Large Molecule Injectable Drugs Market Size, 2018-2030
6.7.5 UAE Large Molecule Injectable Drugs Market Size, 2018-2030
7 Large Molecule Injectable Drugs Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Large Molecule Injectable Drugs Major Product Offerings
7.1.4 Biogen Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Large Molecule Injectable Drugs Major Product Offerings
7.2.4 AstraZeneca Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Large Molecule Injectable Drugs Major Product Offerings
7.3.4 Roche Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Medtronic
7.5.1 Medtronic Company Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Large Molecule Injectable Drugs Major Product Offerings
7.5.4 Medtronic Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.5.5 Medtronic Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Large Molecule Injectable Drugs Major Product Offerings
7.6.4 Novartis Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 ??Baxter
7.7.1 ??Baxter Company Summary
7.7.2 ??Baxter Business Overview
7.7.3 ??Baxter Large Molecule Injectable Drugs Major Product Offerings
7.7.4 ??Baxter Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.7.5 ??Baxter Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Large Molecule Injectable Drugs Major Product Offerings
7.8.4 Amgen Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Large Molecule Injectable Drugs Major Product Offerings
7.9.4 Pfizer Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Large Molecule Injectable Drugs Major Product Offerings
7.10.4 Johnson & Johnson Large Molecule Injectable Drugs Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Large Molecule Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Large Molecule Injectable Drugs Market Drivers in Global Market
Table 3. Large Molecule Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Large Molecule Injectable Drugs in Global Market
Table 5. Top Large Molecule Injectable Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Large Molecule Injectable Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Large Molecule Injectable Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Large Molecule Injectable Drugs Product Type
Table 9. List of Global Tier 1 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Large Molecule Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Large Molecule Injectable Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Large Molecule Injectable Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Large Molecule Injectable Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Large Molecule Injectable Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Biogen Company Summary
Table 31. Biogen Large Molecule Injectable Drugs Product Offerings
Table 32. Biogen Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Biogen Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Large Molecule Injectable Drugs Product Offerings
Table 36. AstraZeneca Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Large Molecule Injectable Drugs Product Offerings
Table 40. Roche Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Sun Pharmaceutical Company Summary
Table 43. Sun Pharmaceutical Large Molecule Injectable Drugs Product Offerings
Table 44. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sun Pharmaceutical Key News & Latest Developments
Table 46. Medtronic Company Summary
Table 47. Medtronic Large Molecule Injectable Drugs Product Offerings
Table 48. Medtronic Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Medtronic Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Large Molecule Injectable Drugs Product Offerings
Table 52. Novartis Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. ??Baxter Company Summary
Table 55. ??Baxter Large Molecule Injectable Drugs Product Offerings
Table 56. ??Baxter Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. ??Baxter Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Large Molecule Injectable Drugs Product Offerings
Table 60. Amgen Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Large Molecule Injectable Drugs Product Offerings
Table 64. Pfizer Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Large Molecule Injectable Drugs Product Offerings
Table 68. Johnson & Johnson Large Molecule Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
List of Figures
Figure 1. Large Molecule Injectable Drugs Segment by Type in 2022
Figure 2. Large Molecule Injectable Drugs Segment by Application in 2022
Figure 3. Global Large Molecule Injectable Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Large Molecule Injectable Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Large Molecule Injectable Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2022
Figure 8. By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Large Molecule Injectable Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 16. US Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 28. China Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Large Molecule Injectable Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Large Molecule Injectable Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Biogen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sun Pharmaceutical Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medtronic Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ??Baxter Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Large Molecule Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
